Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Relmada Therapeutics (RLMD)
NASDAQ:RLMD
RESEARCH TOOLSreports
Holding RLMD?
Track your performance easily
Relmada Therapeutics (RLMD) Ownership Overview
2.40% Insiders
7.26% Mutual Funds
15.36% Other Institutional Investors
5.74% ETFs
69.24% Public Companies and
Individual Investors
The ownership structure of Relmada Therapeutics (RLMD) stock is a mix of institutional, retail, and individual investors. Approximately 28.36% of the company’s stock is owned by Institutional Investors, 2.40% is owned by Insiders, and 69.24% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 11, 2024 | Charles Casamento Director | xxxxxxxxxxxxx | $33280 |
| Sep 11, 2024 | xxxxxxxxxxxxx | $149701 | |
| Sep 11, 2024 | Paul Edward Kelly Director | xxxxxxxxxxxxx | $64750 |
| Sep 11, 2024 | Sergio Traversa Ceo,director | xxxxxxxxxxxxx | $395115 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,205,541 | Institution | 4.00% | 3,375,515 | |
| 1,205,541 | Institution | 4.00% | 3,375,515 | |
| 384,024 | Insider | 1.27% | 1,075,267 | |
| 374,029 | Institution | 1.24% | 1,047,281 | |
| 239,353 | Institution | 0.79% | 670,188 | |
| 224,846 | Institution | 0.75% | 629,569 | |
| 212,295 | Insider | 0.70% | 594,426 | |
| 172,777 | Institution | 0.57% | 483,776 | |
| 110,668 | Institution | 0.37% | 309,870 | |
| 90,689 | Institution | 0.30% | 253,929 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,205,541 | Institution | 4.00% | 3,375,515 | |
| 374,029 | Institution | 1.24% | 1,047,281 | |
| 239,353 | Institution | 0.79% | 670,188 | |
| 172,777 | Institution | 0.57% | 483,776 | |
| 90,689 | Institution | 0.30% | 253,929 | |
| 52,182 | Institution | 0.17% | 146,110 | |
| 20,489 | Institution | 0.07% | 57,369 | |
| 20,223 | Institution | 0.07% | 56,624 | |
| 12,505 | Institution | 0.04% | 35,014 | |
| 3,101 | Institution | 0.01% | 8,683 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 851,916 | Institution | 2.82% | 2,964,668 | |
| 353,625 | Institution | 1.17% | 1,230,615 | |
| 224,846 | Institution | 0.75% | 588,266 | |
| 110,668 | Institution | 0.37% | 309,870 | |
| 90,288 | Institution | 0.30% | 248,292 | |
| 54,584 | Institution | 0.18% | 152,835 | |
| 30,957 | Institution | 0.10% | 85,132 | |
| 14,428 | Institution | 0.05% | 39,677 | |
| 4 | Institution | <0.01% | 11 |
FAQ
Who Owns Relmada Therapeutics (RLMD)?
According to the latest TipRanks data, approximately 15.36% of the company's stock is held by institutional investors, 2.40% is held by insiders, and 69.24% is held by retail investors.
What percentage of Relmada Therapeutics (RLMD) stock is held by institutional investors?
According to the latest TipRanks data, approximately 15.36% of Relmada Therapeutics (RLMD) stock is held by institutional investors.
What percentage of Relmada Therapeutics (RLMD) stock is held by retail investors?
According to the latest TipRanks data, approximately 69.24% of Relmada Therapeutics (RLMD) stock is held by retail investors.
Who owns the most shares of Relmada Therapeutics (RLMD)?
Vanguard owns the most shares of Relmada Therapeutics (RLMD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.